Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
-holder will be a member of the department administration team and be accountable to the ANH Platform Programme and Grants Funding Manager and the Principal Investigator. The post-holder will also be
-
for an experienced leader to play a key role in delivering our new Transformation Programme. You will play a leading role overseeing our exciting programme of activity, working closely with the Senior Leadership Team
-
regional leadership in the area. They will support the Unit’s high- performance computing facility–Uganda Medical Informatics Centre(UMIC) project. The post-holder will develop and implement bioinformatics
-
strategic Community and Performance Sport Coordinator to support QMSU’s elite athlete and community sport development. You will coordinate the Performance Sport Programme and manage the award-winning Sport
-
Research Centre (BRC) programme is Precision Cardiovascular Genomic Medicine, co-led by Professors Panos Deloukas and Patricia Munroe. Our research focuses on (i) deep phenotyping with multi-omics and
-
distribution across residential buildings. In addition to linen operations, the post holder will assist with minor maintenance tasks, move furniture and supplies, and carry out safety checks to help ensure a
-
activities. You will gain in depth knowledge of the student lifecycle and contribute to a wide range of student engagement initiatives, projects, and programme development. Working with Colleges and
-
View All Vacancies Infrastructure Services Division Location: Hawkshead (nr Potters Bar, Herts) Salary: £52,453 to £67,123 Per Annum Including London Weighting Permanent / Full Time Closing Date: 23.59 hours BST on Sunday 03 August 2025 Interview Date: Monday 11 August 2025 Reference: ...
-
, adaptability, and a relentless commitment to client satisfaction. Main Responsibilities Lead the full lifecycle of client programmes, from commercial handover through to post-programme review—delivering to time
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing